Optimality criteria for futility stopping boundaries for group sequential designs with a continuous endpoint
暂无分享,去创建一个
[1] Anastasios A. Tsiatis,et al. Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis , 1994 .
[2] David L. DeMets,et al. Group sequential methods for clinical trials with a one-sided hypothesis , 1980 .
[3] M. Kieser,et al. Choice of futility boundaries for group sequential designs with two endpoints , 2017, BMC Medical Research Methodology.
[4] Implementing type I & type II error spending for two-sided group sequential designs. , 2008, Contemporary clinical trials.
[5] Tze Leung Lai,et al. Futility stopping in clinical trials , 2012 .
[6] P. Gallo,et al. Alternative Views On Setting Clinical Trial Futility Criteria , 2014, Journal of biopharmaceutical statistics.
[7] J Whitehead,et al. Group sequential clinical trials with triangular continuation regions. , 1983, Biometrics.
[8] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[9] Martin Posch,et al. Optimized adaptive enrichment designs , 2017, Statistical methods in medical research.
[10] P. Bauer,et al. Evaluation of experiments with adaptive interim analyses. , 1994, Biometrics.
[11] S. Pocock. Group sequential methods in the design and analysis of clinical trials , 1977 .
[12] P. Gallo,et al. On the Optimal Timing of Futility Interim Analyses , 2017 .
[13] Meinhard Kieser,et al. A variational approach to optimal two‐stage designs , 2019, Statistics in medicine.
[14] Frank Bretz,et al. TUTORIAL IN BIOSTATISTICS Adaptive designs for confirmatory clinical trials , 2022 .
[15] Anastasios A. Tsiatis,et al. Interim Monitoring of Group Sequential Trials Using Spending Functions for the Type I and Type II Error Probabilities , 2001 .
[16] M. Büchler,et al. ChroPac-Trial: Duodenum-preserving pancreatic head resection versus pancreatoduodenectomy for chronic pancreatitis. Trial protocol of a randomised controlled multicentre trial , 2010, Trials.
[17] Draft Guidance. Adaptive Designs for Clinical Trials of Drugs and Biologics , 2018 .
[18] I. K. Hwang,et al. Group sequential designs using both type I and type II error probability spending functions , 1998 .
[19] David L. DeMets,et al. Asymmetric group sequential boundaries for monitoring clinical trials , 1982 .
[20] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[21] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[22] A. Tsiatis,et al. Approximately optimal one-parameter boundaries for group sequential trials. , 1987, Biometrics.